Illinois governor signs law capping insulin costs at $100 per month
I&#x27;m really past the whole &quot;pharma need to charge high prices to fund research&quot; line of argument. Aside from being factually untrue (research funding is dwarfed by marketing for example[0]), it is also arguing for a continued unhealthy relationship with pharmaceutical care.<p>A large amount of research is currently publicly funded. Either via public academic research or directly. When that research bears fruit it is often given away almost at-cost (or below cost when you take into account the larger research landscape) to pharma companies who then privately profit off of it.<p>Pharma companies are profiting off of your tax dollars and then turning around and profiting off of you too. Sure, the benefit exists, but this whole model is broken as all heck.<p>We should just scarp for-profit pharma development as an industry, increase public funding of research, and drug production factories should be a modest profit venture (e.g. 20% of the wholesale cost). Looking more like the generics industry today, where they produce, they don&#x27;t develop.<p>Why do we need a private business to develop drugs at a 40%-1000%+[1] margin when the taxpayer could do it at nearly 0% margin? We&#x27;ve chosen to make it this way, other countries haven&#x27;t, and we see plenty of drugs developed via public institutions around the world.<p>[0] <a href="https:&#x2F;&#x2F;www.bbc.com&#x2F;news&#x2F;business-28212223" rel="nofollow">https:&#x2F;&#x2F;www.bbc.com&#x2F;news&#x2F;business-28212223</a><p>[1] <a href="https:&#x2F;&#x2F;economictimes.indiatimes.com&#x2F;industry&#x2F;healthcare&#x2F;biotech&#x2F;pharmaceuticals&#x2F;retail-margin-on-generic-drugs-may-be-as-high-as-1000-claims-study&#x2F;articleshow&#x2F;58252850.cms?from=mdr" rel="nofollow">https:&#x2F;&#x2F;economictimes.indiatimes.com&#x2F;industry&#x2F;healthcare&#x2F;bio...</a>